Cytokinetics CYTK Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $129.84M+6.0% | $122.52M-45.7% | $225.47M+201% | $74.94M+1.7% | $73.68M-22.3% | ||
| $688.71M-9.3% | $759.7M+3.1% | $737.07M-5.9% | $783.2M-9.4% | $864.54M-11.9% | ||
| $6.83M-61.6% | $17.76M+883% | $1.81M-78.5% | $8.41M+318% | $2.01M-87.9% | ||
| —— | —— | —— | —— | —— | ||
| $13.93M-18.0% | $16.99M+30.6% | $13.01M-35.0% | $20M+26.4% | $15.82M+3.6% | ||
| $839.47M-8.5% | $916.98M-6.2% | $977.35M+10.2% | $886.54M-7.3% | $956.05M-13.7% | ||
| $82.44M+4.1% | $79.19M+4.2% | $76M+8.2% | $70.22M+4.5% | $67.18M+2.1% | ||
| $74.55M-1.9% | $75.98M-2.1% | $77.58M+1.9% | $76.12M-1.7% | $77.44M+3.0% | ||
| $18.47M+6.5% | $17.34M+3.2% | $16.81M+15.5% | $14.55M+14.6% | $12.7M+64.8% | ||
| $254.72M-24.0% | $335.05M+16.0% | $288.82M+62.1% | $178.2M+18.3% | $150.69M+3.9% | ||
| $1.27B-10.6% | $1.42B-0.8% | $1.44B+17.2% | $1.23B-3.0% | $1.26B-9.8% | ||
| $24.71M+10.6% | $22.34M+1.1% | $22.08M+36.1% | $16.23M+16.4% | $13.94M-31.6% | ||
| $8.59M+124% | $3.83M+92.8% | $1.99M-79.3% | $9.59M+64.8% | $5.82M-40.7% | ||
| $1.65M+2.5% | $1.61M0.0% | $1.61M— | —— | —— | ||
| $44.81M+8.8% | $41.18M+138% | $17.28M+20.0% | $14.4M+11.1% | $12.96M+12.5% | ||
| $20.96M+9.7% | $19.11M-7.4% | $20.65M+5.4% | $19.59M+0.1% | $19.57M+3.1% | ||
| $199.19M-1.6% | $202.45M+42.4% | $142.14M+8.5% | $131.06M-17.9% | $159.73M-11.1% | ||
| $247.21M+0.3% | $246.38M+55.2% | $158.75M-0.2% | $159.06M+72.8% | $92.03M-1.3% | ||
| $105.24M-2.5% | $107.97M-2.4% | $110.66M-0.3% | $111.03M-2.1% | $113.35M+0.7% | ||
| —— | —— | $1.61M-20.0% | $2.02M-28.6% | $2.82M— | ||
| $2.1B+0.8% | $2.08B+6.5% | $1.96B+22.8% | $1.59B+4.2% | $1.53B-0.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $124K+0.8% | $123K+0.8% | $122K+2.5% | $119K0.0% | $119K+0.8% | ||
| $2.87B+1.5% | $2.83B+1.6% | $2.78B+5.8% | $2.63B+1.3% | $2.6B+1.2% | ||
| -$3.69B-5.9% | -$3.49B-5.5% | -$3.3B-10.2% | -$3B-4.7% | -$2.86B-6.0% | ||
| -$1.61M-356% | $630K+1,753% | $34K+122% | -$158K-110% | $1.55M-35.6% | ||
| -$826.57M-25.3% | -$659.63M-26.6% | -$521.12M-41.3% | -$368.72M-38.4% | -$266.41M-96.8% | ||
| $1.27B-10.6% | $1.42B-0.8% | $1.44B+17.2% | $1.23B-3.0% | $1.26B-9.8% | ||
| —— | —— | —— | —— | —— | ||
| $688.71M-9.3% | $759.7M+3.1% | $737.07M-5.9% | $783.2M-9.4% | $864.54M-11.9% | ||
| $18.47M+6.5% | $17.34M+3.2% | $16.81M+15.5% | $14.55M+14.6% | $12.7M+64.8% | ||
| $74.55M-1.9% | $75.98M-2.1% | $77.58M+1.9% | $76.12M-1.7% | $77.44M+3.0% | ||
| $254.72M-24.0% | $335.05M+16.0% | $288.82M+62.1% | $178.2M+18.3% | $150.69M+3.9% | ||
| $74.55M-1.9% | $75.98M-2.1% | $77.58M+1.9% | $76.12M-1.7% | $77.44M+3.0% | ||
| $18.47M+6.5% | $17.34M+3.2% | $16.81M+15.5% | $14.55M+14.6% | $12.7M+64.8% | ||
| $74.55M-1.9% | $75.98M-2.1% | $77.58M+1.9% | $76.12M-1.7% | $77.44M+3.0% | ||
| $18.47M+6.5% | $17.34M+3.2% | $16.81M+15.5% | $14.55M+14.6% | $12.7M+64.8% | ||
| $68.86M-17.3% | $83.28M+35.1% | $61.63M+17.8% | $52.32M+20.7% | $43.36M-21.6% | ||
| $68.86M-17.3% | $83.28M+35.1% | $61.63M+17.8% | $52.32M+20.7% | $43.36M-21.6% | ||
| $1.65M+2.5% | $1.61M0.0% | $1.61M— | —— | —— | ||
| $29.6M-4.8% | $31.1M+84.0% | $16.9M-4.0% | $17.6M+50.4% | $11.7M— | ||
| $8.59M+124% | $3.83M+92.8% | $1.99M-79.3% | $9.59M+64.8% | $5.82M-40.7% | ||
| $29.6M-4.8% | $31.1M+84.0% | $16.9M-4.0% | $17.6M+50.4% | $11.7M— | ||
| $418.21M+0.9% | $414.65M+34.9% | $307.33M+1.1% | $304.07M+27.8% | $237.91M+0.6% | ||
| $2.87B+1.5% | $2.83B+1.6% | $2.78B+5.8% | $2.63B+1.3% | $2.6B+1.2% | ||
| $124K+0.8% | $123K+0.8% | $122K+2.5% | $119K0.0% | $119K+0.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $539.11M+3.6% | $520.56M+3.2% | $504.5M+3.1% | $489.5M+2.8% | $476.3M+3.1% | ||
| $138.8M+1.2% | $137.2M-8.8% | $150.5M+1.9% | $147.7M+11.0% | $133.1M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cytokinetics's total assets?
- Cytokinetics (CYTK) holds $1.3B in total assets, up 0.8% year over year.
- How much debt does Cytokinetics have?
- Cytokinetics carries $418.2M in total debt against -$826.6M of shareholders' equity, a debt-to-equity ratio of 2.21.
- How much cash does Cytokinetics have?
- Cytokinetics holds $129.8M in cash and equivalents.
- Can Cytokinetics cover its short-term obligations?
- Its current ratio is 4.21 — current assets exceed current liabilities.
- Where does Cytokinetics's balance sheet data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
